Plasma Pharmacokinetics of Veledimex, a Small-Molecule Activator Ligand for a Proprietary Gene Therapy Promoter System, in Healthy Subjects-Reference-Cited by-同舟云学术

Plasma Pharmacokinetics of Veledimex, a Small-Molecule Activator Ligand for a Proprietary Gene Therapy Promoter System, in Healthy Subjects

Published:2016-08-04 Issue:3 Volume:6 Page:246-257
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Cai Hongliang¹,Sun Lei¹,Miao John¹,Krishman Suma²,Lebel Francois¹,Barrett John A.¹

Affiliation:

1. ZIOPHARM Oncology Inc.; Boston MA USA

2. INTREXON Corporation; Germantown MD USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.287/fullpdf

Reference35 articles.

1. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer;Robertson;Clin Cancer Res,1999

2. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies;Atkins;Clin Cancer Res,1997

3. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response;Gollob;Clin Cancer Res,2000

4. Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma;Lenzi;J Transl Med,2007

5. Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma;Alatrash;J Clin Oncol.,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma;Pharmaceuticals;2023-05-26

2. Advances in local therapy for glioblastoma — taking the fight to the tumour;Nature Reviews Neurology;2022-03-11

3. Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial;Neuro-Oncology;2021-11-26

4. The role of small molecules in cell and gene therapy;RSC Medicinal Chemistry;2021

5. Externally-Controlled Systems for Immunotherapy: From Bench to Bedside;Frontiers in Immunology;2020-09-04